Published in Nucleic Acids Res on February 15, 1997
DNA interstrand crosslink repair in mammalian cells: step by step. Crit Rev Biochem Mol Biol (2010) 1.82
Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis. Nucleic Acids Res (2012) 1.14
Walking of antitumor bifunctional trinuclear PtII complex on double-helical DNA. Nucleic Acids Res (2010) 0.82
Pt-bridges in various single-strand and double-helix DNA sequences. DFT and MP2 study of the cisplatin coordination with guanine, adenine, and cytosine. J Mol Model (2006) 0.76
A new method for sequencing DNA. Proc Natl Acad Sci U S A (1977) 250.51
Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry (1985) 3.67
The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol Ther (1987) 2.96
Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. Science (1992) 2.79
Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J Biol Chem (1994) 2.36
Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA. Biochemistry (1986) 2.09
Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA. Proc Natl Acad Sci U S A (1991) 1.79
Solution structure of a cisplatin-induced DNA interstrand cross-link. Science (1995) 1.70
Cross-linking of complementary strands of DNA in mammalian cells by antitumour platinum compounds. Nature (1972) 1.50
Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol Cell Biol (1992) 1.39
Chemical probes of the conformation of DNA modified by cis-diamminedichloroplatinum(II). Biochemistry (1989) 1.25
Sequence-dependent distortions induced in DNA by monofunctional platinum(II) binding. Biochemistry (1992) 1.24
DNA adducts of cis-diamminedichloroplatinum(II) and its trans isomer inhibit RNA polymerase II differentially in vivo. Biochemistry (1995) 1.18
Structure and isomerization of an intrastrand cisplatin-cross-linked octamer DNA duplex by NMR analysis. Biochemistry (1995) 1.15
Studies related to antitumor antibiotics. Part V. Reactions of mitomycin C with DNA examined by ethidium fluorescence assay. Can J Biochem (1976) 1.13
Role of ligand exchange processes in the reaction kinetics of the antitumor drug cis-diamminedichloroplatinum(II) with its targets. Cancer Res (1985) 1.06
DNA double helix promotes a linkage isomerization reaction in trans-diamminedichloroplatinum(II)-modified DNA. Proc Natl Acad Sci U S A (1994) 1.03
Spectrum of DNA--platinum adduct recognition by prokaryotic and eukaryotic DNA-dependent RNA polymerases. Biochemistry (1993) 1.03
Quantitative estimation of cisplatin-induced DNA interstrand cross-links and their repair in mammalian cells: relationship to toxicity. Pharmacol Ther (1987) 1.02
Base sequence-independent distorsions induced by interstrand cross-links in cis-diamminedichloroplatinum (II)-modified DNA. Nucleic Acids Res (1994) 1.00
Distortions induced in DNA by cis-platinum interstrand adducts. Biochemistry (1992) 0.98
Possible catalytic activity of DNA in the reaction between the antitumor drug cis-diamminedichloroplatinum(II) and the intercalator N-methyl-2,7-diazapyrenium. Proc Natl Acad Sci U S A (1991) 0.98
Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA. Nucleic Acids Res (1993) 0.96
Formation of a DNA monofunctional cis-platinum adduct cross-linking the intercalating drug N-methyl-2,7-diazapyrenium. Nucleic Acids Res (1990) 0.94
Deficient gene specific repair of cisplatin-induced lesions in Xeroderma pigmentosum and Fanconi's anemia cell lines. Carcinogenesis (1993) 0.91
The reaction of platinum(II) complexes with DNA. Kinetics of intrastrand crosslink formation in vitro. Nucleic Acids Res (1991) 0.91
Homodinuclear (Pt,Pt) and heterodinuclear (Ru,Pt) metal compounds as DNA-protein cross-linking agents: potential suicide DNA lesions. Biochemistry (1993) 0.87
NMR solution structure of a DNA decamer containing an interstrand cross-link of the antitumor drug cis-diamminedichloroplatinum (II). J Biomol Struct Dyn (1996) 0.87
How effective are chemical and biological sterilization indicators? J Healthc Mater Manage (1991) 0.77
A simple method for the inactivation of monofunctionally DNA-bound cis-diamminedichloroplatinum (II). J Inorg Biochem (1984) 0.77
A new approach to the measurement of quality of life. The Patient-Generated Index. Med Care (1994) 3.14
A study of polyadenylic acid at neutral pH. J Mol Biol (1966) 2.99
Conformation of poly(dG-dC) . poly(dG-dC) modified by the carcinogens N-acetoxy-N-acetyl-2-aminofluorene and N-hydroxy-N-2-aminofluorene. Proc Natl Acad Sci U S A (1980) 2.25
The preferential interactions of polylysine and polyarginine with specific base sequences in DNA. Proc Natl Acad Sci U S A (1966) 2.13
Chemically modified nucleic acids as immunodetectable probes in hybridization experiments. Proc Natl Acad Sci U S A (1984) 1.98
Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA. Proc Natl Acad Sci U S A (1991) 1.79
DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues. Proc Natl Acad Sci U S A (1993) 1.65
Deoxyribonucleic acid-polylysine complexes. Structure and nucleotide specificity. Biochemistry (1969) 1.59
Salt-dependent dynamic structure of poly(dG-dC) x poly(dG-dC). Nature (1980) 1.53
Conformational changes of poly(dG-dC) . poly(dG-dC) modified by the carcinogen N-acetoxy-N-acetyl-2-aminofluorene. Nucleic Acids Res (1981) 1.50
GreA and GreB proteins revive backtracked RNA polymerase in vivo by promoting transcript trimming. EMBO J (2000) 1.39
Crystal structure of a double-stranded DNA containing a cisplatin interstrand cross-link at 1.63 A resolution: hydration at the platinated site. Nucleic Acids Res (1999) 1.33
The B goes to Z transition of poly(dG-dC) . poly(dG-dC) modified by some platinum derivatives. Nucleic Acids Res (1981) 1.32
Interaction of spermine and DNA. Biopolymers (1967) 1.32
Interaction between antibodies to Z-form deoxyribonucleic acid and double-stranded polynucleotides. Biochemistry (1982) 1.31
Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II). Biochemistry (1991) 1.29
Risk of cardiovascular disease in first and second generation Mexican-Americans. J Immigr Minor Health (2011) 1.26
Chemical probes of the conformation of DNA modified by cis-diamminedichloroplatinum(II). Biochemistry (1989) 1.25
Antiserum to Z-DNA. FEBS Lett (1981) 1.25
Electron microscopic visualization of N-acetoxy-N-2-acetylaminofluorene binding sites in ColE1 DNA by means of specific antibodies. Proc Natl Acad Sci U S A (1979) 1.24
Sequence-dependent distortions induced in DNA by monofunctional platinum(II) binding. Biochemistry (1992) 1.24
Antibodies to DNA modified by the carcinogen N-acetoxy-N-2-acetylaminofluorene. FEBS Lett (1978) 1.20
Distortions induced in double-stranded oligonucleotides by the binding of cis- or trans-diammine-dichloroplatinum(II) to the d(GTG) sequence. Nucleic Acids Res (1990) 1.20
Synthesis and structural studies of a self-complementary decadeoxynucleotide d(AATTGCAATT). I.-Synthesis and chemical characterization of the decanucleotide. Biochimie (1981) 1.17
Comparison of poly(dG-dC).poly(dG-dC) conformations in oriented films and in solution. Proc Natl Acad Sci U S A (1982) 1.16
Characterization of the ternary complexes formed in the reaction of cis-diamminedichloroplatinum (II), ethidium bromide and nucleic acids. Nucleic Acids Res (1987) 1.15
DNA conformational change produced by the site-specific interstrand cross-link of trans-diamminedichloroplatinum(II). Biochemistry (1993) 1.15
Z-DNA immunoreactivity in rat tissues. Nature (1983) 1.14
Conformational changes induced in DNA by in vitro reaction with N-hydroxy-N-2-aminofluorene. Nucleic Acids Res (1979) 1.14
[Photochemisyry of polynucleotides. 3. Study of the fluorescence of polynucleotides at ordinary temperature]. Biochim Biophys Acta (1968) 1.13
A study of polyuridylic acid. J Mol Biol (1971) 1.13
A study of chemically methylated deoxyribonucleic acid. Eur J Biochem (1971) 1.12
Reactivity of antibodies to guanosine modified by the carcinogen N-acetoxy-N-2-acetylaminofluorene. Nucleic Acids Res (1979) 1.10
Solvation of the left-handed hexamer d(5BrC-G-5BrC-G-5 BrC-G) in crystals grown at two temperatures. J Mol Biol (1986) 1.10
Ring-opened alkylated guanine is not repaired in Z-DNA. Nature (1984) 1.09
Spectroscopic studies of (m5dC-dG)3: thermal stability of B- and Z-forms. Nucleic Acids Res (1983) 1.07
The B reversible Z transition of poly(dI-br5dC).poly(dI-br5dC). A quantitative description of the Z form dynamic structure. Nucleic Acids Res (1982) 1.04
Conformation of acetylaminofluorene and aminofluorene modified guanosine and guanosine derivatives. Biochem Biophys Res Commun (1980) 1.04
DNA double helix promotes a linkage isomerization reaction in trans-diamminedichloroplatinum(II)-modified DNA. Proc Natl Acad Sci U S A (1994) 1.03
Reactivity of the antibodies to DNA modified by the carcinogen N-acetoxy-N-acetyl-2-aminofluorene. Biochemistry (1979) 1.03
Spectrum of DNA--platinum adduct recognition by prokaryotic and eukaryotic DNA-dependent RNA polymerases. Biochemistry (1993) 1.03
Reaction of nucleic acids and cis-diamminedichloroplatinum(II) in the presence of intercalating agents. Proc Natl Acad Sci U S A (1986) 1.03
Z-DNA immunoreactivity in fixed metaphase chromosomes of primates. Proc Natl Acad Sci U S A (1983) 1.01
Conformation of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II). Biochemistry (1989) 1.01
RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinum(II). Biochemistry (1992) 1.01
The supercoiling sensitivity of a bacterial tRNA promoter parallels its responsiveness to stringent control. EMBO J (1998) 1.00
Chloroacetaldehyde reacts with Z-DNA. J Mol Biol (1988) 1.00
Base sequence-independent distorsions induced by interstrand cross-links in cis-diamminedichloroplatinum (II)-modified DNA. Nucleic Acids Res (1994) 1.00
Alkaline stability of guanosine and some of its derivatives modified by the carcinogen N-acetoxyacetylaminofluorene. Nucleic Acids Res (1979) 0.99
Further studies on the interaction between polynucleotides and antibodies to poly(inosinic acid). poly(cytidylic acid). Biochemistry (1978) 0.99
Identification of left-handed Z-DNA by indirect immunofluorescence in polytene chromosomes of Chironomus thummi thummi. Exp Cell Res (1982) 0.99
Distortions induced in DNA by cis-platinum interstrand adducts. Biochemistry (1992) 0.98
Possible catalytic activity of DNA in the reaction between the antitumor drug cis-diamminedichloroplatinum(II) and the intercalator N-methyl-2,7-diazapyrenium. Proc Natl Acad Sci U S A (1991) 0.98
Visualization of Z sequences in form V of pBR322 by immuno-electron microscopy. EMBO J (1982) 0.97
Immunochemical studies of DNA modified by cis-dichlorodiammineplatinum(II) in vivo and in vitro. Cancer Res (1981) 0.97
The Drosophila DSP1 gene encoding an HMG 1-like protein: genomic organization, evolutionary conservation and expression. Gene (1997) 0.97
Structural modification and protein recognition of DNA modified by N-2-fluorenylacetamide, its 7-iodo derivative, and by N-2-fluorenamine. Natl Cancer Inst Monogr (1981) 0.97
HMG boxes of DSP1 protein interact with the rel homology domain of transcription factors. Nucleic Acids Res (2000) 0.96
Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA. Nucleic Acids Res (1993) 0.96
In vivo evidence for back and forth oscillations of the transcription elongation complex. EMBO J (1999) 0.96
Intrastrand cross-links are not formed in the reaction between transplatin and native DNA: relation with the clinical inefficiency of transplatin. Nucleic Acids Res (1995) 0.95
Linkage isomerization reaction of intrastrand cross-links in trans-diamminedichloroplatinum(II)-modified single-stranded oligonucleotides. Nucleic Acids Res (1995) 0.95
Left-handed Z-DNA. Biochim Biophys Acta (1985) 0.94
Formation of a DNA monofunctional cis-platinum adduct cross-linking the intercalating drug N-methyl-2,7-diazapyrenium. Nucleic Acids Res (1990) 0.94
Inhibition of in vitro and ex vivo translation by a transplatin-modified oligo(2'-O-methylribonucleotide) directed against the HIV-1 gag-pol frameshift signal. Nucleic Acids Res (2000) 0.94
DSP1, an HMG-like protein, is involved in the regulation of homeotic genes. Genetics (2001) 0.94
Overexpression of the Arabidopsis thaliana MinD1 gene alters chloroplast size and number in transgenic tobacco plants. Planta (2001) 0.93
Biophysical analysis of DNA modified by 1,2-diaminocyclohexane platinum(II) complexes. Nucleic Acids Res (1992) 0.93
Interaction between proflavine and chemically methylated deoxyribonucleic acid. Biochim Biophys Acta (1972) 0.92
Poly(dA-dT).poly(dA-dT) two-pathway proton exchange mechanism. Effect of general and specific base catalysis on deuteration rates. Biochemistry (1986) 0.92
High resolution mapping of E.coli transcription elongation complex in situ reveals protein interactions with the non-transcribed strand. EMBO J (1996) 0.92
Interaction between polyribouridylic acid and spermine. Biochimie (1972) 0.92
Reaction of cis-diamminedichloroplatinum (II) and DNA in B or Z conformation. EMBO J (1984) 0.91
Purification and specificity of antibodies to adenosine. Biochimie (1977) 0.90
Reaction of nucleic acids with cis-diamminedichloroplatinum(II): interstrand cross-links. Biochemistry (1987) 0.90
"Asymmetric" opening reaction mechanism of Z-DNA base pairs: a hydrogen exchange study. Biochemistry (1985) 0.90
In situ hybridization of an acetylaminofluorene-modified probe recognized by Z-DNA antibodies in vitro. Cytogenet Cell Genet (1986) 0.89
Comparison between poly(dG-dC).poly(dG-dC) and DNA modified by cis-diamminedichloroplatinum (II): immunological and spectroscopic studies. J Biomol Struct Dyn (1985) 0.89
NMR solution structure of a DNA dodecamer containing a transplatin interstrand GN7-CN3 cross-link. Nucleic Acids Res (1999) 0.89
Assessment of high-affinity hybridization, RNase H cleavage, and covalent linkage in translation arrest by antisense oligonucleotides. Antisense Nucleic Acid Drug Dev (1998) 0.89
Reactivity of monofunctional cis-platinum adducts as a function of DNA sequence. Nucleic Acids Res (1988) 0.88
Transplatin-modified oligo(2'-O-methyl ribonucleotide)s: a new tool for selective modulation of gene expression. Biochemistry (1997) 0.88
Chemical versatility of transplatin monofunctional adducts within multiple site-specifically platinated DNA. Biochemistry (1997) 0.88
NMR solution structure of a DNA decamer containing an interstrand cross-link of the antitumor drug cis-diamminedichloroplatinum (II). J Biomol Struct Dyn (1996) 0.87
Antibodies to adenosine 5'-monophosphate: purification and specificity. Eur J Biochem (1975) 0.87
Weight loss and changes in generic and weight-specific quality of life in obese adolescents. Qual Life Res (2010) 0.86
Interaction between cisplatin-modified DNA and the HMG boxes of HMG 1: DNase I footprinting and circular dichroism. J Mol Biol (1995) 0.86
Interstrand cross-links of cisplatin induce striking distortions in DNA. J Inorg Biochem (1999) 0.86
Transplatin-modified oligonucleotides as modulators of gene expression. Pharmacol Ther (2000) 0.85
Interstrand cross-linking reaction in triplexes containing a monofunctional transplatin-adduct. Nucleic Acids Res (1996) 0.85
Interstrand crosslinking reaction in transplatin-modified oligo-2'-O-methyl ribonucleotide-RNA hybrids. Antisense Nucleic Acid Drug Dev (1997) 0.85
Discrimination by antibodies between local defects in DNA induced by 2-aminofluorene derivatives. FEBS Lett (1979) 0.85